WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'2201 Infant (under 12 months) mortality rate: 812
GDP / capita (US$): 2'0391 Child (under 5 years) mortality rate: 1152

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 19'840  19'390  18'977  18'601  18'260  16'131  12'116  8'266 
Births 731  715  698  682  668  614  503  400 
Surviving infants 675  659  642  625  611  555  450  353 
Pop. less than 5 years 3'088  2'997  2'935  2'872  2'828  2'637  2'107  1'599 
Pop. less than 15 years 8'227  8'070  7'935  7'797  7'674  6'791  5'392  3'757 
Female 15-49 years 4'675  4'548  4'427  4'325  4'230  3'660  2'560  1'703 

Number of reported case

(Click for retrospective incidence data for Côte d'Ivoire)
Diphtheria
Japanese encephalitis
Measles 137  628  441  183  12  5'729  17'799  7'633 
Mumps
Pertussis 3'052 
Polio* 36  26  28  47 
Rubella 298  43  31  51  113 
Rubella (CRS)
Tetanus (neonatal) 15  30  364 
Tetanus (total) 15  384 
Yellow fever 10  49  22  14 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Côte d'Ivoire)
Vaccine year result method % card seen                                                
BCG 2011  83  DHS/MICS   74.1  98  74  91  95  91  76 
DTP1 2011  78  DHS/MICS   74.1  99*  75  95  95  89  83 
DTP3 2011  64  DHS/MICS   74.1  99  62  85  81  74  62 
HepB_BD         
HepB3 2009  75  EPI   91.0  99  62  85  81  74 
Hib3          99  62  85  81 
JapEnc         
MCV 2011  65  DHS/MICS   74.1  94  49  70  67  63  62 
MCV2         
PCV1         
PCV3         
Pol3 2011  69  DHS/MICS   74.1  99  58  81  77  58  61  56 
Rota1         
Rota_last         
Rubella1         
TT2plus 2000  70  EPI   98.0  97  59  62  44  40  78 
PAB         
VAD1          99*  99*  88  95 
YFV 2009  41  EPI   91.0  90  49  69  24  50  55 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Côte d'Ivoire)
BCG 99  74  91  95  91  80  62 
DTP1 98  75  95  95  89  85  77 
DTP3 94  62  85  81  74  65  54 
HepB3 94  62  85  81  74 
Hib3 94  62  85  81 
MCV 85  49  70  67  63  68  56 
PAB 82  82  82  92  92  76  36 
PCV3
Pol3 94  58  81  77  58  66  56 
Rota_last
YFV 81  49  69  24  50  60 

Number of districts in the country 82  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 84
From 80 to 89% 9
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT pregnant women 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2011-2015  2011 - 2015  2011-2015  2007-2011  2007-2011  2007-2011  NA 
Nº of districts with microplans that include activities to raise immunization coverage number 82  102  83  83    79  58 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 82  102  83  83  72  79  79 
Nº districts with DTP3 coverage >=80% number 76  14  53  47  35  33  36 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  14  64  57  49  42  46 
Nº districts with measles (MCV1) coverage >=95% number 41     
% of districts with MCV1 coverage >=95% From 0 to 100% 50     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No  No  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 26  30  55  31  31  28 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.